Form 8-K EXELIXIS, INC. For: Oct 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Form 8-K EXELIXIS, INC. For: Oct 29
October 30, 2024 6:27 AM EDT
Stephens analyst Sudan Loganathan raised the price target on Exelixis (NASDAQ: EXEL) to $29.00 (from $23.00) while maintaining a Equal Weight rating.
The analyst comments "EXEL reported 3Q24 financial results yesterday (10/29/2024) after market close and provided regulatory and business updates. Key highlights on the... More
October 30, 2024 5:47 AM EDT
Citi analyst David Lebowitz raised the price target on Exelixis (NASDAQ: EXEL) to $38.00 (from $31.00) while maintaining a Buy rating.
The analyst comments "Exelixis reported 3Q24 financial results, beating consensus on top-line revenue and GAAP EPS due to continued strength of cabozantinib. Total... More
October 29, 2024 4:09 PM EDT
Exelixis (NASDAQ: EXEL) reported Q3 EPS of $0.47, $0.13 better than the analyst estimate of $0.34. Revenue for the quarter came in at $539.5 million versus the consensus estimate of $489.77 million.
GUIDANCE:
Exelixis sees FY2024 revenue of $2.15-2.2 billion, versus the consensus of $2.05... More
